Personalized briefing
Discovery of the day · Neurology
Antiseizure medication use in pregnancy and the risk of poor fetal growth in the EURAP international registry: a prospective cohort study
Dear Damien Boorman, this is your personalized scientific intelligence briefing — curated for your work in Neurology.
Key finding
Medicine · Neurology
Discovery of the day
This prospective cohort study from the EURAP international registry demonstrates that prenatal exposure to antiseizure medications is associated with an increased risk of poor fetal growth, expanding the known adverse outcomes beyond congenital malformations and neurodevelopmental effects. The researchers found that risk varies significantly across individual antiseizure monotherapies and specific drug combinations, with risk escalating as the number of concomitant antiseizure medications increases. These findings provide critical evidence for preconception counselling and individualized treatment selection, directly informing clinical decisions that aim to optimize both maternal neurological care and fetal outcomes — a mechanistic and translational insight highly relevant to your work in preclinical models of chronic pain and your broader commitment to improving patient well-being through rigorous scientific evidence.
Novelty
94%
Rigor
96%
Significance
91%
Validity
93%
Clarity
95%
Advertisement
GroupRFQ — join group deals on lab & medical equipment. Pool orders, unlock volume pricing. See open deals →
Your briefing is personalized based on your selected fields, keywords, and research interests.
